Recurrent Metastatic Squamous Neck Cancer With Occult Primary Completed Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0029502 (Recurrent Metastatic Squamous Neck Cancer With Occult Primary)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01316757Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerTreatment